On The Pen: The Weekly Dose 7.9.24

Ozempic reduces cancer risk:

• https://www.bloomberg.com/news/articles/2024-07-05/ozempic-may-lower-risk-of-obesity-related-cancers-study-finds

Semaglutide correlated with blindness (tiktok video):

• https://www.statnews.com/2024/07/03/ozempic-wegovy-naion-vision-loss-study

15-years as type-2 diabetic results in a 78% chance of have some degree of retinal eye damage

• https://www.webmd.com/diabetes/closer-look-diabetic-retinopathy

Update to Mounjaro/ZepBound FDA shortage on 7/2/2024 (tiktok video)
#releasethevials

• https://www.accessdata.fda.gov/scripts/drugshortages/dsp_ActiveIngredientDetails.cfm?AI=Tirzepatide%20Injection&st=c

Mounjaro KwikPen coming to Australia

• News provided by Mimi from Australia (Mimi featured in Live #61 -- part of Retatrutide trials

GIP scientific study:

• https://bpspubs.onlinelibrary.wiley.com/doi/10.1111/bph.16478

semaglutide vs. tirzepatide

•  https://www.nbcnews.com/health/health-news/zepbound-outperforms-ozempic-wegovy-head-head-weight-loss-study-rcna160630

Keto diet:

• https://www.biorxiv.org/content/10.1101/2024.06.14.599117v1

High-price of GLP-1 medications:

• https://www.usatoday.com/story/opinion/2024/07/02/biden-sanders-prescription-drug-cost-ozempic-wegovy/74232827007/?tbref=hp